Commentary: cortisone acetate administered orally in dermatologic therapy.
D000284:Administration, Oral; D002386:Cataract / Q000139:chemically induced; D003872:Dermatitis / Q000188:drug therapy; D004334:Drug Administration Schedule; D006801:Humans; D007030:Hypothalamo-Hypophyseal System / Q000187:drug effects; D007263:Infusions, Parenteral; D010913:Pituitary-Adrenal System / Q000187:drug effects; D011239:Prednisolone / Q000008:administration & dosage* / Q000009:adverse effects; D012871:Skin Diseases / Q000188:drug therapy*
D011239:Prednisolone